| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A brief report on combination chemotherapy and anti–programmed death (ligand) 1 treatment in small-cell lung cancer: Did we choose the optimal chemotherapy backbone?
|
Mankor, Joanne M.
|
|
|
137 |
C |
p. 40-44
|
artikel
|
| 2 |
Active surveillance in desmoid-type fibromatosis: A systematic literature review
|
Timbergen, Milea J.M.
|
|
|
137 |
C |
p. 18-29
|
artikel
|
| 3 |
A phase II study of pazopanib as front-line therapy in patients with non-resectable or metastatic soft-tissue sarcomas who are not candidates for chemotherapy
|
Hirbe, Angela C.
|
|
|
137 |
C |
p. 1-9
|
artikel
|
| 4 |
A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies
|
Federico, Sara M.
|
|
|
137 |
C |
p. 204-213
|
artikel
|
| 5 |
Benefit of adjuvant chemotherapy in high-risk colon cancer: A 17-year population-based analysis of 6131 patients with Union for International Cancer Control stage II T4N0M0 colon cancer
|
Teufel, Andreas
|
|
|
137 |
C |
p. 148-160
|
artikel
|
| 6 |
Can we replace adjuvant chemotherapy with surveillance for stage IA-C immature ovarian teratomas of any grade? an international multicenter analysis
|
Bergamini, Alice
|
|
|
137 |
C |
p. 136-143
|
artikel
|
| 7 |
Chemokine biology on immune checkpoint–targeted therapies
|
Letourneur, Diane
|
|
|
137 |
C |
p. 260-271
|
artikel
|
| 8 |
Chemotherapy beyond immune checkpoint inhibitors in patients with metastatic colorectal cancer
|
Martin-Romano, Patricia
|
|
|
137 |
C |
p. 117-126
|
artikel
|
| 9 |
Clinically significant bleeding with immune checkpoint inhibitors: A retrospective cohort study
|
Kewan, Tariq
|
|
|
137 |
C |
p. 285-287
|
artikel
|
| 10 |
Coronavirus disease (COVID-19) outbreak and phase 1 trials: should we consider a specific patient management?
|
Postel-Vinay, Sophie
|
|
|
137 |
C |
p. 235-239
|
artikel
|
| 11 |
Corrigendum to “Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database” [Eur J Canc 125, (January 2020) 153–163]
|
Delanoy, Nicolas
|
|
|
137 |
C |
p. 288-289
|
artikel
|
| 12 |
Cost-effectiveness analysis of the 70-gene signature compared with clinical assessment in breast cancer based on a randomised controlled trial
|
Retèl, Valesca P.
|
|
|
137 |
C |
p. 193-203
|
artikel
|
| 13 |
Erratum to ‘Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database’ [European Journal of Cancer, Volume 125 (January 2020) Pages 153–163]
|
Delanoy, Nicolas
|
|
|
137 |
C |
p. 290-291
|
artikel
|
| 14 |
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors
|
Coart, Elisabeth
|
|
|
137 |
C |
p. 171-174
|
artikel
|
| 15 |
Fibrolamellar carcinoma: Challenging the challenge
|
Lamarca, Angela
|
|
|
137 |
C |
p. 144-147
|
artikel
|
| 16 |
First-line gemcitabine plus nab-paclitaxel for elderly patients with metastatic pancreatic cancer: Crossing the frontier of age?
|
Vivaldi, Caterina
|
|
|
137 |
C |
p. 108-116
|
artikel
|
| 17 |
Histopathological grading affects survival in patients with IDH-mutant grade II and grade III diffuse gliomas
|
Franceschi, Enrico
|
|
|
137 |
C |
p. 10-17
|
artikel
|
| 18 |
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study)
|
Kurreck, Annika
|
|
|
137 |
C |
p. 81-92
|
artikel
|
| 19 |
Impact of sex and age on chemotherapy efficacy, toxicity and survival in localised oesophagogastric cancer: A pooled analysis of 3265 individual patient data from four large randomised trials (OE02, OE05, MAGIC and ST03)
|
Athauda, Avani
|
|
|
137 |
C |
p. 45-56
|
artikel
|
| 20 |
KRAS inhibition in non–small cell lung cancer: Past failures, new findings and upcoming challenges
|
Passiglia, Francesco
|
|
|
137 |
C |
p. 57-68
|
artikel
|
| 21 |
Lymphoblastic predominance of blastic phase in children with chronic myeloid leukaemia treated with imatinib: A report from the I-CML-Ped Study
|
Meyran, Deborah
|
|
|
137 |
C |
p. 224-234
|
artikel
|
| 22 |
Palliative care delivery according to age in 12,000 women with metastatic breast cancer: Analysis in the multicentre ESME-MBC cohort 2008–2016
|
Frasca, Matthieu
|
|
|
137 |
C |
p. 240-249
|
artikel
|
| 23 |
Ramucirumab and durvalumab for previously treated, advanced non–small-cell lung cancer, gastric/gastro-oesophageal junction adenocarcinoma, or hepatocellular carcinoma: An open-label, phase Ia/b study (JVDJ)
|
Bang, Yung-Jue
|
|
|
137 |
C |
p. 272-284
|
artikel
|
| 24 |
Sentinel lymph node mapping and intraoperative assessment in a prospective, international, multicentre, observational trial of patients with cervical cancer: The SENTIX trial
|
Cibula, David
|
|
|
137 |
C |
p. 69-80
|
artikel
|
| 25 |
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial
|
Stahler, Arndt
|
|
|
137 |
C |
p. 250-259
|
artikel
|
| 26 |
SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment
|
Szumera-Ciećkiewicz, Anna
|
|
|
137 |
C |
p. 175-182
|
artikel
|
| 27 |
Spotlight on the treatment of infantile fibrosarcoma in the era of neurotrophic tropomyosin receptor kinase inhibitors: International consensus and remaining controversies
|
Orbach, Daniel
|
|
|
137 |
C |
p. 183-192
|
artikel
|
| 28 |
Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands – A nationwide population-based study
|
van Zeijl, Michiel C.T.
|
|
|
137 |
C |
p. 127-135
|
artikel
|
| 29 |
Timing of sentinel node biopsy independently predicts disease-free and overall survival in clinical stage I-II melanoma patients: A multicentre study of the Italian Melanoma Intergroup (IMI)
|
Mandalà, Mario
|
|
|
137 |
C |
p. 30-39
|
artikel
|
| 30 |
Trends in incidence, diagnosis, treatment and survival of hepatocellular carcinoma in a low-incidence country: Data from the Netherlands in the period 2009–2016
|
Reinders, Margot T.M.
|
|
|
137 |
C |
p. 214-223
|
artikel
|
| 31 |
Updated EORTC QLQ-C30 general population norm data for Germany
|
Nolte, Sandra
|
|
|
137 |
C |
p. 161-170
|
artikel
|
| 32 |
Xenograft-derived mRNA/miR and protein interaction networks of systemic dissemination in human prostate cancer
|
Lange, Tobias
|
|
|
137 |
C |
p. 93-107
|
artikel
|
Tijdschrift beschrijving